Results 11 to 20 of about 5,263 (229)

A novel effective treatment for menière’s disease - dextroamphetamine sulfate

Clinical and Experimental Obstetrics & Gynecology, 2020
Purpose: To determine if treatment with dextroamphetamine sulfate could ameliorate the symptoms of long-standing Menière’s disease in a menopausal woman with a past history of dysmenorrhea.
J.H. Check, D. Check, R. Cohen
doaj   +3 more sources

Dextroamphetamine (but Not Atomoxetine) Induces Reanimation from General Anesthesia: Implications for the Roles of Dopamine and Norepinephrine in Active Emergence. [PDF]

PLoS ONE, 2015
Methylphenidate induces reanimation (active emergence) from general anesthesia in rodents, and recent evidence suggests that dopaminergic neurotransmission is important in producing this effect. Dextroamphetamine causes the direct release of dopamine and
Jonathan D Kenny, Norman E Taylor, Emery N Brown, Ken Solt   +3 more
doaj   +3 more sources

Using a controlled stimulant to treat cocaine use disorder in the setting of attention deficit/hyperactivity disorder: a case study [PDF]

Frontiers in Psychiatry
Cocaine Use Disorder (CUD), like all other stimulant use disorders, remains a challenging condition to treat, particularly in the absence of FDA-approved pharmacotherapies.
Mack Bozman, Brent Collier, Aniket Malhotra, Gray McPherson, Li Li   +4 more
doaj   +2 more sources

Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority Trial. [PDF]

CNS Drugs
Although there are several treatments for narcolepsy type 2 and idiopathic hypersomnia, studies that assess amphetamines, symptoms beyond sleepiness, and comparative effectiveness are needed. We performed a randomized, fully blinded, noninferiority trial
Trotti LM, Blake T, Hoque R, Rye DB, Sharma S, Bliwise DL.   +5 more
europepmc   +2 more sources

Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial

JAMA Neurology, 2018
Importance Data from animal models show that the administration of dextroamphetamine combined with task-relevant training facilitates recovery after focal brain injury. Results of clinical trials in patients with stroke have been inconsistent. Objectives
L. Goldstein, L. Lennihan, Meheroz J. Rabadi, D. Good, M. Reding, A. Dromerick, G. Samsa, John A. Pura   +7 more
semanticscholar   +2 more sources

Raynaud's phenomenon during treatment with lisdexamfetamine: risk of cerebral vasospasm? [PDF]

Einstein (São Paulo)
Lisdexamfetamine, a prodrug used to treat Attention Deficit/Hyperactivity Disorder in children, adolescents, and adults, is an inactive substance that is converted into its active form (dextroamphetamine) after being metabolized.
Rubens Pitliuk, Tatyanny Paula Pinto da Costa Santos Fucci   +1 more
doaj   +2 more sources

Dextroamphetamine Sulfate

Definitions, 2020
Recommended Jul 2017 This draft guidance, when finalized, will represent the current thinking of the Food and Drug Administration (FDA, or the Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public.
openaire   +2 more sources

EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants [PDF]

Neuropsychopharmacology, 2022
The poor translatability between preclinical and clinical drug trials has limited pro-cognitive therapeutic development. Future pro-cognitive drug trials should use translatable cross-species cognitive tasks with biomarkers (1) relevant to specific ...
Savita G. Bhakta, J. Cavanagh, J. Talledo, Juliana E. Kotz, Lindsay Benster, Benjamin Z. Roberts, John A. Nungaray, J. Brigman, G. Light, N. Swerdlow, Jared W. Young   +10 more
semanticscholar   +2 more sources

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system

Frontiers in Pharmacology, 2023
Background: Methylphenidate, atomoxetine, and Amphetamine are the three most commonly used medications approved by the United States Food and Drug Administration (FDA) for the treatment of attention deficit/hyperactivity disorder (ADHD).
Wei Wei, Wei Wei, Wei Wei, Li Chen, Li Chen, Hui Zhou, Hui Zhou, Jinfeng Liu, Yue Zhang, Shiyu Feng, Shiyu Feng, Shiyu Feng, Yingtao Bai, Yanen Leng, En Chang, Liang Huang, Liang Huang   +16 more
doaj   +1 more source

Psychostimulants in the Treatment of Depressive Disorders [PDF]

Psikiyatride Güncel Yaklaşımlar, 2015
Despite antidepressant therapy of appropriate trial duration and dose optimization, 50-60% of depressed patients have an adequate treatment response, whereas only 35-40% achieve remission.
Okan Ekinci, Asli Erkan Ekinci, Selahattin Bolek   +2 more
doaj   +1 more source